5.13
5.13 (0.00%)
| Volume | 1,221,151 |
| 52 Weeks Range |
| Profit Margin | -15.96% |
| Operating Margin (TTM) | -9.49% |
| Diluted EPS (TTM) | -0.700 |
| Quarterly Revenue Growth (YOY) | 10.30% |
| Total Debt/Equity (MRQ) | 2,020.06% |
| Current Ratio (MRQ) | 1.79 |
| Operating Cash Flow (TTM) | -15.64 M |
| Levered Free Cash Flow (TTM) | 5.58 M |
| Return on Assets (TTM) | -17.66% |
| Return on Equity (TTM) | -277.62% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Bullish | Mixed | |
| Stock | The Oncology Institute, Inc. | Mixed | Mixed |
AIStockmoo Score
| Value 35% | -1.4 |
| AI Insight info | NA |
| Relative Valuation info | NA |
| Financial Health info | -1.4 |
| Timing 35% | 0.0 |
| AI Technical info | NA |
| Technical Oscillators info | 0.0 |
| Technical Moving Averages info | 0.0 |
| Smart Money 30% | 0.0 |
| Analyst Consensus info | 0.0 |
| Insider Activity info | NA |
| Environment | ×1.09 |
| Macro Environment info | -3.3 |
| Sector vs Market (6M) | +8.7% |
| Pillar Agreement | ×1.00 |
| Not in score | |
| Price Volatility info | NA |
| Final Score | -0.53 |
Select this tab to load the latest available analysis.
|
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Value |
| % Held by Insiders | 9.22% |
| % Held by Institutions | 34.63% |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |